IDEAYA Biosciences (NASDAQ:IDYA – Get Rating) had its price target hoisted by Guggenheim from $32.00 to $40.00 in a report published on Monday, The Fly reports. Several other research analysts have also recently issued reports on IDYA. Berenberg Bank started coverage on shares of IDEAYA Biosciences in a report on Thursday, March 23rd. They issued […]
IDEAYA Biosciences (NASDAQ:IDYA – Get Rating) had its target price hoisted by Wedbush from $30.00 to $35.00 in a research note published on Monday morning, The Fly reports. IDYA has been the subject of several other research reports. TheStreet cut shares of IDEAYA Biosciences from a c- rating to a d+ rating in a research […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating) has been given an average rating of “Moderate Buy” by the eleven ratings firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month […]
IGM Biosciences (NASDAQ:IGMS – Get Rating) had its price objective trimmed by Morgan Stanley from $30.00 to $20.00 in a research report report published on Monday, Benzinga reports. The brokerage currently has an equal weight rating on the stock. Several other equities research analysts also recently issued reports on the company. Royal Bank of Canada […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Rating) insider George Gauthier sold 935 shares of the stock in a transaction dated Wednesday, April 5th. The stock was sold at an average price of $12.60, for a total transaction of $11,781.00. Following the sale, the insider now owns 33,878 shares in the company, valued at approximately $426,862.80. […]